Trousseau Syndrome
Trousseau syndrome, also known as paraneoplastic migratory superficial thrombophlebitis, is a dangerous systemic hypercoagulable state. It was first described in 1865 by the renowned clinician Armand Trousseau, who later recognized the syndrome in himself as a sign of his own advanced pancreatic cancer.
The syndrome is marked by recurrent blood clots (thromboses) that inflame superficial veins throughout the body. The lesions are "migratory": they settle in one place and then flare up unexpectedly somewhere else. More than 90% of cases are directly linked to advanced mucin-secreting adenocarcinomas, including:
- Pancreatic adenocarcinoma: the most common cause (40–50% of cases).
- Gastric carcinoma.
- Non-small cell lung cancer (NSCLC).
- Ovarian, colorectal and prostate cancers.
At the molecular level, adenocarcinoma cells release large amounts of sialylated mucin into the circulation. Mucin binds directly to L-selectin on white blood cells and P-selectin on platelets, triggering widespread platelet aggregation that bypasses the usual clotting cascade. At the same time, the tumor continuously sheds tissue factor (TF) and microparticles, causing a cascade of microvascular clotting, deep vein thrombosis (DVT), pulmonary embolism (PE) and nonbacterial thrombotic (marantic) endocarditis (NBTE).
At Haute-Derma, we treat Trousseau syndrome as a medical emergency, because a venous clot can travel to the heart and lungs and cause sudden death before the underlying cancer has produced obvious symptoms.
Clinical Features: Skin and Systemic Signs
The vein changes in Trousseau syndrome are quite distinctive, yet they are easily mistaken for a minor injury or ordinary skin inflammation:
- Migratory Superficial Vein Lesions:
- Appearance: Firm, cord-like papules, streaks or nodules follow the course of a superficial vein. The overlying skin is red, swollen, warm and very tender to the touch.
- Migratory pattern: A lesion in one place (for example, the forearm) may fade on its own within 1–3 weeks, only for a new one to appear straight away or shortly afterwards somewhere else (the trunk, thigh, lower leg or breast).
- The affected veins are typically otherwise normal, with no previous history of varicose veins.
- Serious Systemic Thromboembolic Events:
- Deep vein thrombosis (DVT): Sudden painful swelling and tightness of one calf or thigh.
- Pulmonary embolism (PE): Sudden shortness of breath, sharp chest pain on breathing in, coughing up blood and low blood pressure.
- Arterial embolism / NBTE: Clots forming on the heart valves can travel to the brain and cause a large ischemic stroke, even in young patients with no cardiovascular risk factors.
Diagnosis and Clinical Management at Haute-Derma
When a patient comes to Haute-Derma with red, painful, migrating streaks along the veins, our doctors follow an emergency protocol:
Dermoscopy and Urgent Vascular Doppler Ultrasound
- Digital dermoscopy: Shows an infiltrated red-purple band along the vessel and a dilated superficial vascular network, with no signs of surface infection.
- Venous Doppler ultrasound (performed immediately): Confirms whether a clot is fully or partly blocking the superficial vein and checks whether it has extended into the deep veins (DVT).
Cosmetic Procedures and Massage Are Strictly Contraindicated
- No massage, sclerotherapy, laser, liposuction or surgery: Massage, rubbing, hot compresses, vein sclerotherapy, heat-based RF or laser treatments and any cosmetic surgery must not be performed anywhere on the patient's body.
- Risk of death: Massaging or squeezing a clotted vein can break off clots that travel to the right side of the heart, causing acute pulmonary embolism (PE), circulatory arrest and death on the spot.
Emergency Referral to Oncology and Hematology
The patient is referred urgently and directly to a general hospital or a hematology and oncology center for:
- Coagulation and vascular tests: D-dimer (usually very high), fibrinogen, prothrombin time (PT/INR) and APTT.
- Targeted anticoagulation: Low-molecular-weight heparin (LMWH) is started immediately. Clinical note: Warfarin is often ineffective in Trousseau syndrome because the mucin-driven mechanism does not depend on vitamin K, and evidence for DOACs in this syndrome is limited. LMWH is the preferred choice.
- Screening for advanced adenocarcinoma:
- Contrast-enhanced CT of the chest, abdomen and pelvis: Focused on tumors of the pancreatic head, stomach, lungs and ovaries.
- Tumor markers: CA 19-9 (pancreas/biliary tract), CEA (gastrointestinal/lung), CA 125 (ovary).
- Upper endoscopy and colonoscopy if gastrointestinal cancer is suspected.
